摘要
为改善幼年特发性关节炎(juvenile idiopathic arthritis,JIA)患儿预后,继2019年发布的针对多关节型JIA、骶髂关节炎、附着点炎及JIA相关葡萄膜炎患儿的治疗指导后,美国风湿病学会(American College of Rheumatology,ACR)于2022年3月发布了新的JIA治疗指南,内容包括药物治疗和非药物治疗两部分,其中药物治疗部分主要针对少关节型和全身型JIA(systemic JIA,sJIA)及颞颌关节炎。本文将对指南主要内容进行解读,以供临床医生借鉴和参考。
In order to improve the prognosis of children with juvenile idiopathic arthritis(JIA),following the treatment guideline issued in 2019,the American College of Rheumatology(ACR)published new guidelines for the treatment of JIA in March 2022,including recommendations for both pharmacologic and nonpharmacologic therapies.The pharmacologic management focuses on treatment of oligoarthritis,temporomandibular joint arthritis,and systemic JIA.This article provides Chinese physicians with detailed interpretation of this guideline,for the purpose of better applying it in their clinical practice.
作者
钟林庆
宋红梅
ZHONG Linqing;SONG Hongmei(Department of Pediatrics,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)
出处
《协和医学杂志》
CSCD
2022年第6期992-998,共7页
Medical Journal of Peking Union Medical College Hospital
基金
国家重点研发计划(2021YFC2702003)
北京市自然科学基金(L202050)
中央高水平医院临床科研专项(2022-PUMCH-B-079)。
关键词
幼年特发性关节炎
治疗
指南
儿童
juvenile idiopathic arthritis
treatment
guideline
children
